Covered recipient · General Payments record
JUSTIN LAMAR SMITH
General Payments · PY2018–2024
$2,121.09
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $569.01 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $245.89 | 19 |
| Lilly USA, LLC | $83.61 | 5 |
| CARDIVA MEDICAL, INC. | $52.28 | 1 |
| Amgen Inc. | $46.21 | 3 |
| Abbott Laboratories | $41.88 | 2 |
| SHIELD THERAPEUTICS INC | $31.29 | 2 |
| Phathom Pharmaceuticals, Inc. | $18.70 | 1 |
| Acerta Pharma LLC | $17.46 | 1 |
| Novo Nordisk AS | $16.01 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.88 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125367705 | CMS |
| Abbott Laboratories | $21.00 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125367707 | CMS |
| ABBVIE INC. | $24.54 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124506 | CMS |
| ABBVIE INC. | $19.63 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124508 | CMS |
| ABBVIE INC. | $7.53 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124510 | CMS |
| ABBVIE INC. | $4.46 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124512 | CMS |
| ABBVIE INC. | $15.09 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124514 | CMS |
| ABBVIE INC. | $20.14 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124516 | CMS |
| ABBVIE INC. | $11.03 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124518 | CMS |
| ABBVIE INC. | $12.20 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124520 | CMS |
| ABBVIE INC. | $23.45 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124522 | CMS |
| ABBVIE INC. | $19.21 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124524 | CMS |
| ABBVIE INC. | $8.74 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124526 | CMS |
| ABBVIE INC. | $10.60 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124528 | CMS |
| ABBVIE INC. | $5.05 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124530 | CMS |
| ABBVIE INC. | $8.69 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124532 | CMS |
| ABBVIE INC. | $7.48 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124534 | CMS |
| ABBVIE INC. | $5.23 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124536 | CMS |
| ABBVIE INC. | $16.36 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124538 | CMS |
| ABBVIE INC. | $19.27 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124540 | CMS |
| ABBVIE INC. | $7.19 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106124542 | CMS |
| Amgen Inc. | $17.12 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117386620 | CMS |
| Amgen Inc. | $14.09 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117386622 | CMS |
| Amgen Inc. | $15.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117386624 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.46 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104315684 | CMS |
| Boston Scientific Corporation | $15.68 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092391312 | CMS |
| CARDIVA MEDICAL, INC. | $52.28 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143861726 | CMS |
| Lilly USA, LLC | $14.76 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075649 | CMS |
| Lilly USA, LLC | $18.93 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135102281 | CMS |
| Lilly USA, LLC | $16.03 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135111960 | CMS |
| Lilly USA, LLC | $15.34 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135087184 | CMS |
| Lilly USA, LLC | $18.55 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135090829 | CMS |
| Novo Nordisk Inc | $16.01 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097482408 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.70 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151127680 | CMS |
| SHIELD THERAPEUTICS INC | $15.67 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150133223 | CMS |
| SHIELD THERAPEUTICS INC | $15.62 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150144902 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.